Edwards Lifesciences/EW

$86.15

-1.81%
-
1D1W1MYTD1YMAX

About Edwards Lifesciences

Edwards Lifesciences Corporation is a manufacturer of heart valve systems and repair products used to replace or repair a patient's diseased or defective heart valve. Its products and technologies are categorized into four main areas: Transcatheter Aortic Valve Replacement, Transcatheter Mitral and Tricuspid Therapies, Surgical Structural Heart, and Critical Care. It also develops hemodynamic and noninvasive brain and tissue oxygenation monitoring systems used to measure a patient's cardiovascular function in the hospital setting. The Edwards SAPIEN family of valves, including the Edwards SAPIEN 3, the Edwards SAPIEN 3 Ultra, and the Edwards SAPIEN 3 Ultra RESILIA systems, are catheter-based approaches for treating severe symptomatic aortic stenosis. It conducts operations worldwide and is managed in various geographical regions, including the United States, Europe, Japan, and Rest of World. It sells products that are used to treat advanced cardiovascular disease in all regions.

Ticker

EW

Sector

Healthcare

Trading on

NYSE

Industry

Medical Equipment & Supplies

CEO

Bernard Zovighian

Employees

19,800

Headquarters

Irvine, United States

EW Metrics

BasicAdvanced
$52.76B
Market cap
38.12
P/E ratio
$2.30
EPS
1.06
Beta
-
Dividend rate

What the Analysts think about EW

Analyst Ratings

Majority rating from 31 analysts.
Buy

Price Targets

Average projection from 25 analysts.
5.07% upside
High $102.00
Low $67.00
$86.15
Current price
$90.52
Average price target

EW Financial Performance

Income StatementBalance sheetCash Flow

Income Statement

Revenues and expenses
24.11% profit margin
QuarterlyAnnual
Q4 23
QoQ growth
Revenue
$1.53B
3.59%
Net income
$369.9M
-3.9%
Profit margin
24.11%
-7.23%

EW Earnings Performance

Earnings per share (EPS)

Company profitability
Beat by 0.41%
QuarterlyAnnual
Q1 23
Q2 23
Q3 23
Q4 23
Q1 24
Actual
$0.62
$0.66
$0.59
$0.64
-
Expected
$0.61
$0.65
$0.59
$0.64
$0.64
Surprise
2.1%
2.03%
-0.4%
0.41%
-
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon. Fundamental data, financials and analyst ratings are sourced from Refinitiv.

Upcoming events

Buy or sell Edwards Lifesciences stock

Buy or sell Edwards Lifesciences stock

Stocks, funds and up to 4.50% interest earned on uninvested cash. When you invest, your capital is at risk.
Start investing